Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
116 hedge funds and large institutions have $66.6M invested in Sanofi Contingent Value Rights in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 11 closing their positions.
36% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 11
1% more funds holding
Funds holding: 115 → 116 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $74M → $66.6M (-$7.42M)
33% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EM
Elliott Management
New York
|
+$7.32M |
| 2 |
MCM
Moore Capital Management
New York
|
+$685K |
| 3 |
DAM
Deltec Asset Management
New York
|
+$598K |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$423K |
| 5 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
+$164K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
Fir Tree Capital Management
New York
|
-$12.9M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$4.09M |
| 3 |
LCM
Lonestar Capital Management
San Francisco,
California
|
-$1.24M |
| 4 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
-$203K |
| 5 |
Millennium Management
New York
|
-$142K |
GCVRZ Hedge Fund Activity: Q2 2015 in Review
116 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2015, worth a combined $66.6M — down 10% from $74M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new GCVRZ positions and 11 closed out — a net gain of 4 holders — while 14 added to existing stakes and 21 trimmed.
The largest buyer was Elliott Management, adding an estimated $7.32M. The largest seller was Fir Tree Capital Management, exiting entirely with an estimated $12.9M sold.
- 116 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2015, up from 115 in Q1 2015.
- Funds reported $66.6M of Sanofi Contingent Value Rights stock for Q2 2015, down 10% quarter-over-quarter.
- 15 funds opened new Sanofi Contingent Value Rights positions in Q2 2015 and 11 closed out, a net change of +4 holders.
- The largest Sanofi Contingent Value Rights buyer in Q2 2015 was Elliott Management, an estimated $7.32M added.
- The largest Sanofi Contingent Value Rights seller in Q2 2015 was Fir Tree Capital Management, an estimated $12.9M sold.
Based on aggregated 13F filings for Q2 2015.